April 7 Health Systems Antibiotics Study could renew recommendations for vancomycin dosing and monitoring goals in critically ill patients PT April 2023 The safety and efficacy of area under the curve (AUC) monitoring in ICU patients receiving continuous renal replacement therapy (CRRT) has yet to be validated by the literature, but a new study by Wang and colleagues published in Pharmacotherapy on January 30, 2023, seems to shine light on the topic. Corey Diamond, PharmD
April 7 Drugs & Diseases On The Shelf Raspberry leaf for pregnancy PT April 2023 Herbs and herbal products have been used during pregnancy for centuries and have recently become popular through the widespread belief that it is “safer to go natural.” Mickie Cathers
April 7 Drugs & Diseases New Drugs Sunlenca PT April 2023 In December 2022, FDA approved Sunlenca (Gilead Sciences, Inc.), the first medication in a new class of drugs used to treat HIV type 1 (HIV-1) in patients who are unable to be successfully treated with other available medications. Lauren Howell, PharmD
April 7 Drugs & Diseases Supplements What are the top 10 supplements in the U.S.? PT April 2023 With 77% of Americans taking at least one supplement on a regular basis, it is more important than ever for pharmacists to know about these products. Lauren Howell, PharmD
April 7 Drugs & Diseases Diabetes What changed and what stayed the same for diabetes management in CKD? PT April 2023 With a large amount of new, high-quality data available, the Kidney Disease: Improving Global Outcomes (KDIGO) workgroup issued a new comprehensive update on diabetes management in chronic kidney disease (CKD) only 2 short years after the last comprehensive update became available. Ariel L. Clark, PharmD
April 7 Drugs & Diseases Osteoporosis ACP updates osteoporosis and low bone mass guidelines PT April 2023 At the start of 2023, the American College of Physicians (ACP) released an update to their pharmacological guideline recommendations for the treatment of osteoporosis and low bone mass to prevent fractures in adults. Clarissa Chan, PharmD
April 7 Drugs & Diseases Depression Ketamine can serve as remedy for treatment-resistant depression PT April 2023 For individuals with suicidal thoughts or who don’t respond to any therapies for depression, ketamine offers a treatment choice, according to Megan Ehret, PharmD, BCPP, from the University of Maryland School of Pharmacy. Loren Bonner